baber/WOPTO huggingface dataset:
Patent NZ-235548-A (NZ)
Title: Use of coenzyme q as an antioxidant in food, fat, cosmetic or pharmaceutical products
Inventor: BRACCO UMBERTO
IPC: A23L29/00
Filed: 1990-10-03
Abstract: To protect an oxidation-sensitive fatty substance or a food, cosmetic or pharmaceutical product containing an oxidation-sensitive fatty substance, in particular an oil rich in polyunsaturated fatty acids, coenzyme Q is employed, if appropriate in combination with ascorbic acid and a natural emulsifier.
Patent NZ-241347-A (NZ)
Title: Polyamine thiol derivatives and pharmaceutical compositions
Inventor: EDWARDS MICHAEL LOUIS
IPC: C07C323/34
Filed: 1992-01-21
Abstract: The present invention relates to compounds of formula (1) or (2) which are useful as radioprotective agents. <CHEM>  wherein  n is an integer from 0 to 3,  m is an integer from 4 to 9,  Z is a C2-C6 alkylene group, A is H, -SH, -SPO3H2, -N(CH2)q-SH, -N(CH2)q-SPO3H2, wherein q is an integer 2 to 4, and  B1 and B2 are each independently H, -(CH2)q-SH, or -(CH2)q-SPO3H2, <CHEM>  wherein  n is an integer from 0 to 3,  Z is a C2-C6 alkylene group, A is H, -SH, -SPO3H2, -N(CH2)q-SH, -N(CH2)q-SPO3H2, wherein q is an integer 2 to 4, and  B1 and B2 are each independently H, -(CH2)q-SH, or -(CH2)q-SPO3H2, with the proviso that at least one of A, B1 and B2 is other than H.
Patent NZ-247719-A (NZ)
Title: Pin-tumbler lock with supplementary pin retainer
Inventor: PREDDEY BRIAN
IPC: E05B27/00
Filed: 1993-05-27
Abstract: The invention relates to an improvement in a key-actuated pin tumbler lock (10) of the type having: a cylindrical core (12) rotatable in a lock housing (24) via a rotational path (30), a plurality of pin tumblers (14, 16) received in bores (22, 23) journalled in the core (12) and lock housing (24), each bore (22, 23) containing a set of pin tumblers comprising one core (14) and one housing pin (16), biassed towards the core (12), and having a     a pin junction (20) therebetween, and     a key slot (28) in the core (12), whereby insertion in the key slot (28) of a key (31) having thereon suitable bits is adapted to align the pin junctions (20) with the rotational path (30) of the core (12) in the lock housing (24), and to permit the core (12) to rotate within the housing (24). The improvement comprises a retaining mechanism (32, 34) adapted to bias at least one of the pin tumblers (14, 16) towards engagement with the rotational path (30) of the core (12), the mechanism (32, 34) being adapted to restrain rotation of the core (12) until release of the or each biassed pin tumbler (14, 16) upon insertion of a key (31) including, as well as the suitable bits, means (35) for disengaging the retaining mechanism (32, 34) from engagement with the or each biassed pin tumbler (14, 16). <IMAGE>
Patent NZ-260545-A (NZ)
Title: Mount for cushion spring; mount has foot element formed on the end of pneumatic spring members, the element having means for attaching it to a frame
Inventor: WAGNER ROBERT F
IPC: F16F1/12
Filed: 1992-02-05
Abstract: Pneumatic and load-supporting spring devices are used in bedding, cushions and the like. These have tubular telescoping members (16,18) that are biased apart by either an elastomer located in the overlapping region or a helical spring located within the pneumatic cylinder formed by the tubes. A conical or dish-shaped head element (70) with clips (76) provides a mount for the device, in which the clips securely engage a typical wire grid found in many bedding products. Additionally the dish-shaped element may use cooperating lobe(122) and trough (124) pairs to hold a grid wire (158) therebetween to fix the spring device (20) in place.
Patent NZ-297532-A (NZ)
Title: High purity N-(4-[N,N-Bis(2-iodoethyl)amino]phenoscycarbonyl)-L-Glutamic acid
Inventor: HEATON DAVID WILLIAM
IPC: A61P43/00
Filed: 1995-12-21
Abstract: A new salt of a prodrug useful in antibody directed enzyme prodrug therapy (ADEPT) is disclosed.  A hydrogen iodide salt of the prodrug N-(4-[N,N-bis(2-iodoethyl)amino]phenoxycarbonyl)-L-glutamic acid is prepared which can be obtained in crystalline form.  Preparation of the crystalline form of the prodrug enables preparation of the prodrug in highly pure form.
Patent NZ-324603-A (NZ)
Title: Treatment of the CNS effects of HIV with VX-478, alone or in combination with AZT or 3TC
Inventor: CHATURVEDI PRAVIN RAMSEWAK
IPC: A61P31/00
Filed: 1996-12-05
Abstract: Use of the HIV protease inhibitor of formula I for the treatment of the CNS effects of a virus (especially HIV).
Patent NZ-329862-A (NZ)
Title: Poly(ether)hydroxyls, esters, or fatty acids as waterproofing agents optionally in conjunction with quaternary ammonium compositions
Inventor: WALKER LEIGH
IPC: B27K3/34
Filed: 1994-06-09
Abstract: Polyhydroxyl and polyether hydroxyl esters of fatty acids and polyether hydroxides are provided as waterproofers. These waterproofers are also combined with quaternary ammonium compositions and a solvent in waterproofing, wood preservative systems. Preferred quaternary ammonium compounds have chloride, hydroxide, carbonate, carboxylate, or borate counter ions.
Patent NZ-332606-A (NZ)
Title: Esculetin derivatives substituted by a beta linked sugar residue or a phosphate group or a carboxylate group, their use as substrates for detecting microorganisms
Inventor: JAMES ARTHUR
IPC: C07D311/14
Filed: 1997-05-01
Abstract: The invention concerns novel 6- or 7-substituted derivatives of esculetin (6,7-dihydroxy-2H-1-benzopyran-2-one), their synthesis, and their application as substrates for the detection of micro-organisms in samples where a derivative is enzymatically cleaved to release a colored or fluorogenic marker which has a low tendency to diffuse through agar or other aqueous environments.
Patent NZ-332746-A (NZ)
Title: Transdermal propentofylline compositions for the treatment of Alzheimer's disease
Inventor: VENKATESHWARAN SRINIVASAN
IPC: A61L15/58
Filed: 1997-08-22
Abstract: ethod for the transdermal delivery of propentofylline compositions.  Patients suffering from Alhzheimer's disease are treated by transdermally administering an effective amount of 1, 2, 3, 6-tetrahydro-3-methyl-1-(3-oxohexyl)-7-propylpurine-2, 6-dione in the form of an occlusive device containing a delivery composition comprising a carrier vehicle having uniformly distributed therein effective amount of propentofylline and, optionally, a penetration enhancer. The occlusive device may be a matrix type patch in which the carrier vehicle is a pressure sensitive adhesive or a reservoir type patch in which the carrier vehicle is a liquid of controlled viscosity, i.e. a gel, wherein the reservoir system contains means for maintaining it in a propentofylline transferring relationship with the derma when applied. Daily dosages of between about 5 and 49 mg/day are sufficient to maintain adequate plasma propentofylline levels.
Patent NZ-337360-A (NZ)
Title: Use of calcium or barium hydroxide in a process for the electrochemical treatment of concrete to remove chloride ions and absorb chlorine
Inventor: MILLER JOHN B
IPC: C04B41/53
Filed: 1998-02-12
Abstract: A process for the electro-chemical treatment of concrete comprising passing a direct electric current between an anode associated with a layer of electrolyte applied to an external surface of the concrete and a cathode which is located internally in the concrete. The process causes chloride ions to migrate to the anode and to reduce the production of chlorine gas, the electrolyte layer contains calcium hydroxide or barium hydroxide as a chlorine scavenger.
Patent NZ-502324-A (NZ)
Title: Boat hull construction process using two grooved and cut flat panels
Inventor: KELSALL DEREK HAMMERSLEY
IPC: B63B9/06
Filed: 2000-01-17
Abstract: There is provided methods of constructing a boat hull, the methods including constructing two hull panels on a substantially horizontal surface, each said panel being substantially a mirror image of the other and representing substantially a half of the hull between the deck line and the keel line, and cutting grooves in portions of each panel in certain areas that must bend sufficiently when the final hull shape is being formed.  Also, the method includes setting the two hull panels together and using tie members to form the desired hull shape by progressively tightening the tie members by exerting a downward force on the hull panels from the joined keel line toward the open deck line.
Patent NZ-502905-A (NZ)
Title: Apparatus for measuring the viscosity of a fluid (e.g. blood)
Inventor: KENSEY KENNETH
IPC: A61B8/12
Filed: 1998-08-26
Abstract: An apparatus for use in measuring the viscosity of blood (30) circulating within a living being (28), the apparatus comprising: i) means (26) for placing the circulating blood (30) into contact with a second fluid (42) in an elongate container (44) whereby the length of the fluid changes as a result of the contact; ii) signal generating means (50) arranged to generate a signal according to movement of the length; and iii) calculating means (52) arranged to calculate the viscosity of the blood from the generated signals. Also described is an apparatus for determining the viscosity of a first fluid at plural shear rates, the apparatus comprising: i) a first tube (26) through which the first fluid flows; ii) a supply (38) of a second fluid communicating with a second tube (34) which has a riser tube (44) arranged to form a column (42) of the second fluid; iii) sensors (50) for determining the height of the fluid column (42) in the riser tube (44) and to generate signals according to the height sensed; iv) computing means (52) arranged to calculate the viscosity from the signals.
Patent NZ-504141-A (NZ)
Title: Fungicide composition comprising a copper source and a calcium, zinc or manganese chelate
Inventor: LE BRAS EDWIGE
IPC: A01N59/20
Filed: 2000-04-20
Abstract: The specification describes a process for the protection of plants against fungal diseases, particularly, Plasmopara viticola.  The process involves treating plants with, in combination, a non-chelated copper source such as Bordeaux mixture, copper carbonate, copper hydroxide, copper oxychloride and a sparingly soluble calcium and/or zinc and/or manganese chelate.  In situ the resulting soluble copper chelate is gradually released.
Patent NZ-504517-A (NZ)
Title: A boat roller
Inventor: THOMPSON PATRICK ANDREW
IPC: B60B19/12
Filed: 2000-05-15
Abstract: A non-bushed wide bearing wobble boat roller including in combination a hub and bearing member (10) integrally formed of a rigid, wear resistant material, having a hub portion (13) and a bearing portion (11), the hub portion (13), when in use, having an outer surface, there being a substantially vertical outer surface and a substantially horizontal outer surface, or running surface, the bearing portion (11) having a bore (16) with an internal bearing surface (12) of a shape adapted to enable the roller to rotate about an axle member with a wobbling motion according to load changes on the roller and wherein the length of the bearing portion (11) and the bore (16) is at least as long as the smallest internal diameter of the bore (16).
Patent NZ-506680-A (NZ)
Title: Bifurcated stent with expandable leg sections located and fixed within apertures of expandable stem section
Inventor: RICHTER JACOB
IPC: A61F2/06
Filed: 1999-03-31
Abstract: A bifurcated stent is disclosed with expandable legs located and fixed within apertures of an expandable stem section.
Patent NZ-509544-A (NZ)
Title: Aqueous homogeneous plant growth-regulating compositions comprising at least one quaternary ammonium salt
Inventor: KOBER REINER
IPC: A01N25/30
Filed: 1999-07-12
Abstract: An aqueous homogeneous composition for regulating plant growth has an active compound concentration of at least 20% and comprises: a) at least one active compound of the formula (I)  wherein: R1 is alkyl and R2 is alkyl, cyclopentenyl, haloalkyl or R1 and R2 together are -(CH2)5-, -(CH2)2-O-(CH2)2- or -(CH2)-CH=CH-(CH2)-NH- and X is an anionic group and b) at least one auxiliary selected from b1) alkylglucosides, b2) alkylsulphonates or alkylarylsulphonates of the formula R3-SO2- M(+, ++) wherein: R3 is an aliphatic group -alkylphenoxypolyethoxy, alkylphenyl, alkylnaphthyl and M is a mono- or divalent cationic group.
Patent NZ-511090-A (NZ)
Title: Vehicular warning light having a dichroic element
Inventor: KREUTZER ROBERT E
IPC: F21V9/00
Filed: 1999-11-02
Abstract: A  visible light source adapted to be mounted  on  the vehicle  for generating visible light to be used  to  create warning  signals which are viewed by observers  remote  from the  vehicle.  A dichroic element adapted to be  mounted  on the  vehicle  and  adjacent  to  the  visible  light  source transmits  at  least some of the visible light generated  by the  light source and reflects at least some of the  visible light  generated  by the light source. The  transmitted  and reflected  light  provides  warning  light  signals   within different  wavelength  ranges when  viewed  by  an  observer remote from the vehicle.
Patent NZ-514274-A (NZ)
Title: Water turbine rotor vertically movable with respect to water surface
Inventor: FRAENKEL PETER
IPC: F03B17/06
Filed: 2000-02-23
Abstract: A flowing water actuatable turbine system, wherein the turbine system is mounted for operational co-operation with water current by means of an upstanding column/pile in such manner as to be axially displaceable length ways of the column/pile. The turbine system is preferably arranged to be rotatably about the longitudinal axis of the column. Floatation means can be provided for operationally supporting the turbines, which can include blade pitch control.
Patent NZ-516004-A (NZ)
Title: Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
Inventor: GREEN LARRY L
IPC: C07K16/24
Filed: 2000-06-08
Abstract: A transgene comprising a DNA fragment comprising a DNA sequence of a continuous region of the immunoglobulin heavy chain locus on human chromosome 14 from the D segment genes, continuing through the J segment genes and the constant region gene Cì of that locus, wherein said DNA fragment is operably linked to at least one human V segment gene, and wherein said DNA fragment further is operable linked to an additional constant region gene, said additional constant region gene comprising a mouse gamma-1 switch region and human constant region coding exons, wherein said transgene is a yeast artificial chromosome (YAC).
Patent NZ-518885-A (NZ)
Title: Subsea well intervention vessel
Inventor: HAYNES ANTHONY PATRICK
IPC: B63B35/00
Filed: 2000-12-20
Abstract: A subsea well intervention vessel comprising a dynamically positionable tanker and direct well intervention equipment mounted on a deck of the tanker. The direct well intervention equipment may be mounted on a superstructure above the main deck of the tanker and includes equipment for underbalanced non-rotating drilling and hydrocarbon liquid separation. The liquid separation equipment is coupled to storage tanks of the tanker so as to receive separated hydrocarbon liquids for storage purposes.
Patent NZ-520073-A (NZ)
Title: A prosthetic device for insertion into a joint cavity.
Inventor: PEDERSEN WALTHER BATSBERG
IPC: A61L27/00
Filed: 2000-12-14
Abstract: The present invention relates to a method and a device for alleviating and/or preventing conditions relating to damaged joints involving articulating surfaces. In a first aspect the present invention relates to a prosthetic device for insertion into a joint cavity of a joint of a vertebrate, such as a human, said device consisting of a biocompatible material comprising at least a first polymeric component and a second polymeric component, wherein the chain length of the first polymeric component is longer than the chain length of the second polymeric component, the polymeric components in particular being polyethylene, polypropylene and/or polyvinylpyrrolidone. The device may be used for establishing slidability and/or distributing pressure in a joint of a vertebrate such as a human, by inserting into the joint cavity of the joint a prosthetic device, preferably a prosthetic device as defined in this invention, capable of locking itself to an intra-articular component and thereby being fixed or retained in the joint cavity in a manner which is substantially non-invasive with respect to cartilage and bone natively present in the joint cavity. The device may be formed by moulding, whereby it is possible to adapt the form of the device to the joint needing alleviation. Also the device may be formed with a hole or a slit to fit into the joint and lock the device around intra-articular components. A further aspect of invention relates to a method for introducing the prosthetic device into a joint, such as a method comprising locking the device to an intro- articular component, thereby fixing or retaining the device in the joint cavity in a manner which is substantially non- invasive with respect to cartilage and bone natively present in the joint cavity. Also the invention relates to an instrument for inserting a prosthetic device according to the invention, comprising means for deforming the prosthetic device into a reduced volume or a slender shape and means for grasping the intra-articular component to which the device is capable of interlocking.
Patent NZ-524346-A (NZ)
Title: Solid oral dosage forms of valsartan
Inventor: WAGNER ROBERT FRANK
IPC: A61P9/00
Filed: 2003-02-21
Abstract: A solid oral dosage form comprising as therapeutic agents: (a) an effective amount of valsartan or a pharmaceutically acceptable salt thereof present in an amount below or equal to 35% by weight based on the total weight of the solid oral dosage form; and (b) an effective amount of hydrochlorothiazide (HCTZ); a process of forming a solid oral dosage form; and the use of the dosage form in the manufacture of a medicament for treating hypertension, congestive heart failure, angina, myocardial infarction, atherosclerosis, diabetic nephropathy, diabetic cardiac myopathy, renal insufficiency, peripheral vascular disease, left ventricular hypertrophy, cognitive dysfunction, stroke, headache and chronic heart failure. (62) Divided out of 505863
Patent NZ-528822-A (NZ)
Title: Increasing phosphorus uptake from the gut of dairy cows by supplementing 1 -hydroxylated vitamin D compounds
Inventor: DELUCA HECTOR F
IPC: A23K1/18
Filed: 2002-01-22
Abstract: A feed for dairy cows containing 1 alpha -hydroxylated vitamin D compounds is disclosed. The vitamin D compounds cause improved utilization of dietary phosphorus and can eliminate the need for supplemental quantities of inorganic phosphorus in the cows' diet. In particular, milk production in dairy cows may be maintained in relatively high yield even though fed a low P diet.
Patent NZ-534610-A (NZ)
Title: Method and sampling device for detection of low levels of a property/quality trait present in an inhomogeneously distributed sample substrate
Inventor: TSENG CHING-HUI
IPC: G01N21/35
Filed: 2003-02-25
Abstract: A process for detecting low levels of a predetermined quality trait present in an inhomogeneously distributed particulate substrate involving the steps of: (a) providing a particulate substrate to be analyzed; (b) providing a spectrometer with an electromagnetic detector capable of performing spectroscopic measurements with electromagnetic radiation; (c) providing a rotatable sample holder having a transparent area through which electromagnetic radiation may pass; (d) providing a tumbling member located within the rotatable sample holder for tumbling the particulate substrate contained therein; (e) introducing the particulate substrate into the rotatable sample holder; (f) simultaneously rotating and tumbling the particulate substrate contained within the rotatable sample holder; and (g) activating the spectrometer, thereby illuminating the particulate substrate contained within the rotatable sample holder with electromagnetic radiation.
Patent NZ-535670-A (NZ)
Title: Use of thalidomide analogs for inhibition of angiogenesis
Inventor: D AMATO ROBERT
IPC: A61K31/404
Filed: 1994-02-24
Abstract: Use of an effective amount of any one of the thalidomide analogs of formulae (A), (B) or (C), in the manufacture of a medicament for treating, preventing or inhibiting undesired angiogenesis in a patient in need thereof is disclosed, wherein the substituents shown in these formulae are as defined in the specification. The undesired angiogenesis may be associated with a disease selected from the group consisting of solid or blood-borne tumors, tumor metastasis, diabetic retinopathy, retinopathy of prematurity, corneal graft rejection, neovascular glaucoma, retrolental fibroplasia, epidemic keratoconjunctivitis, Vitamin A deficiency, contact lens overwear, atopic keratitis, superior limbic keratitis, pterygium keratitis sicca, Sjogren's syndrome, acne rosacea, phylectenulosis, syphilis, Microbacteria infections other than leprosy, lipid degeneration, chemical bums, bacterial ulcers, fungal ulcers, Herpes simplex infections, Herpes zoster infections, protozoan infections, Kaposi's sarcoma, Mooren's ulcer, Terrien's marginal degeneration, marginal keratolysis, trauma, rheumatoid arthritis, systemic lupus erythematosis, polyarteritis, Wegener's syndrome, sarcoidosis, scieritis, Stevens- Johnson disease, pemphigoid, radial keratotomy, macular degeneration, sickle cell anemia, sarcoid, pseudoxanthoma elasticum, Paget's disease, vein occlusion, artery occlusion, carotid obstructive disease, chronic uveitis, chronic vitritis, Lyme's disease, Eales' disease, Behcet's disease, infections causing retinitis or choroiditis, presumed ocular histoplasmosis, Best's disease, myopia, optic pits, Stargardt's disease, pars planitis, chronic retinal detachment, hyperviscosity syndromes, toxoplasmosis, post-laser complications, rubeosis, abnormal proliferation of fibrovascular or fibrous tissue, proliferative vitreoretionophathy, Bartonellosis, hemangiomas, Osler-Weber-Rendu disease, acquired immune deficiency syndrome, ocular neovascular disease, age-related macular degeneration, osteoarthritis, diseases caused by chronic inflanmiation, Crohn's disease, ulcerative colitis, tumors of rhabodomyosarcoma, tumors of retinoblastoma, Ewing's sarcoma, tumors of neuroblastoma, tumors of osteosarcoma, leukemia, psoriasis, atherosclerosis, acoustic neuroma, neurofibroma, trachoma or pyogenic granulomas, vascular malfunctions, and abnormal wound healing.
Patent NZ-542091-A (NZ)
Title: Persistent to-do user interface providing task management and calendar information
Inventor: LEUKART RICHARD H
IPC: G06Q10/10
Filed: 2005-08-30
Abstract: An electronic "To-Do" bar in which displayed upcoming tasks, meetings, appointments and the like. The electronic To-Do bar is displayed in a lightweight menu of tasks, meetings and appointments and is displayed persistently in addition to other software functionality or user interfaces displayed on a user's computer display screen according to other software applications or other software functionality in use. A user is presented with an always-visible list of upcoming tasks, meetings and appointments without the need to launch a separate tasks application or calendar application to view upcoming tasks, meetings or appointments.